Full Press Release Details
KEWAUNEE SCIENTIFIC ANNOUNCES THIRD QUARTER RESULTS AND QUARTERLY DIVIDEND
STATESVILLE, N.C., Feb. 28 /PRNewswire-FirstCall/ -- Kewaunee Scientific
Corporation (Nasdaq: KEQU) today reported results for its third quarter ended
Net earnings for the quarter were $321,000, or $0.13 per diluted share, as
compared to a net loss of $555,000, or $0.22 per diluted share, in the same
period last year. Earnings for the quarter benefited from significantly improved
manufacturing efficiencies, cost improvement initiatives, and lower operating
Sales for the quarter were $18,041,000, an increase of 2% over sales of
$17,724,000 in the same period last year. Modestly lower domestic sales were
offset by increased sales to international customers. Incoming orders were
strong during the quarter. The order backlog increased to $48.6 million at
January 31, 2007, up from $34.3 million at October 31, 2006 and $36.4 million at
"This quarter was an outstanding quarter for incoming orders," said William
A. Shumaker, President and Chief Executive Officer. "Our order backlog increased
by $14.3 million during the quarter and included several prestigious laboratory
furniture projects. This improved backlog will contribute nicely to our sales
and earnings going forward.
"I continue to be pleased with the improved performance of our manufacturing
operations, as we are achieving much-improved manufacturing efficiencies and
lower manufacturing costs," Mr. Shumaker continued. "These improvements,
combined with lower operating expenses, the continued strengthening of our
international business, and the growth in our domestic order backlog, have the
Company on a solid track for continued success and profitability."
The Company's financial condition remains strong. Cash on hand at the end of
the quarter was $1.9 million, up from $1.3 million at April 30, 2006. Working
capital was $11.3 million, up from $11.0 million at April 30, 2006. Total bank
debt and capital lease obligations at January 31, 2007 were $7.0 million, down
from $9.1 million at April 30, 2006, resulting in a debt to equity ratio of
.27-to-1 at the end of the quarter.
Net earnings for the nine months ended January 31, 2007 were $1,023,000, or
$0.41 per diluted share. Net earnings for the comparable period of the prior
year, which benefited from an after-tax gain of $540,000 related to the sale of
the Company's property in Texas, were $447,000, or $0.18 per diluted share.
Excluding this gain on the sale of property, the net loss in the prior year
period was $93,000, or $0.04 per diluted share. Sales for the nine months ended
January 31, 2007 were $58,720,000, a decrease of 3% from sales of $60,351,000 in
the same period last year. Lower domestic sales were partially offset by
increased sales to international customers.
The Company also announced today that its Board of Directors approved a cash
dividend of seven cents per outstanding share to stockholders of record at the
close of business on March 9, 2007, payable on March 23, 2007.
Kewaunee Scientific Corporation is a recognized leader in the design,
manufacture, and installation of scientific and technical furniture. The
Company's corporate headquarters and manufacturing facilities are located in
Statesville, North Carolina. The Company also has subsidiaries in Singapore and
Bangalore, India that serve the Asian markets. Kewaunee Scientific's website is
located at http://www.kewaunee.com.
Certain statements in this release constitute "forward-looking" statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that could significantly impact results or achievements expressed
or implied by such forward-looking statements. These factors include, but are
not limited to, economic, competitive, governmental, and technological factors
affecting the Company's operations, markets, products, services, and prices.
Contact: D. Michael Parker
Consolidated Statements of Operations
(in thousands, except per share data)
* Includes a non-recurring pretax gain of $884,000 and an after-tax gain of
$540,000, or $.22 per diluted share, on the sale of property.
Condensed Consolidated Balance Sheets
----------- ----------
Cash and cash equivalents $ 1,466 $ 929
Restricted cash 413 399
Receivables, less allowances 18,474 23,199
Inventories 5,997 5,860
Prepaid expenses and other current assets 1,029 1,011
Total current assets 27,379 31,398
Net property, plant and equipment 11,451 11,163
Other assets 8,278 7,911
Total Assets $ 47,108 $ 50,472
Liabilities and Stockholders' Equity
Short-term borrowings $ 6,047 $ 8,216
Current obligations under capital leases 352 260
Accounts payable 6,032 9,074
Other current liabilities 3,605 2,823
Total current liabilities 16,036 20,373
Other non-current liabilities 4,992 4,553
Total stockholders' equity 26,080 25,546
Total Liabilities and Stockholders' Equity $ 47,108 $ 50,472
SOURCE Kewaunee Scientific Corporation
/CONTACT: D. Michael Parker of Kewaunee Scientific Corporation,
/Web site: http://www.kewaunee.com/